Literature DB >> 22807559

Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI.

Varun Sethi1, Tarek A Yousry, Nils Muhlert, Maria Ron, Xavier Golay, Claudia Wheeler-Kingshott, David H Miller, Declan T Chard.   

Abstract

OBJECTIVE: Cortical grey matter lesions are common in multiple sclerosis (MS), but usually not seen on MRI. The authors compared the performance of double inversion recovery (DIR, currently considered the best available imaging sequence for detecting cortical lesions) with phase-sensitive inversion recovery (PSIR, a sequence allowing much higher resolution scans to be obtained in a clinically feasible time).
METHODS: Sixty MS patients and 30 healthy controls underwent MRI scanning on a 3 Tesla scanner. The authors compared intracortical (IC) and leucocortical (LC) lesion counts obtained with a standard DIR sequence (1×1×3 mm resolution, obtained in 4 min) and a PSIR sequence (0.5×0.5×2 mm, 11 min). Lesions were marked separately on DIR and PSIR scans.
RESULTS: In the whole MS cohort, more cortical lesions were seen on the higher-resolution PSIR than the DIR scans (IC mean±SD: 18.1±9.8 vs 5.9±4.5, p<0.001; LC mean±SD: 13.4±12.9 vs 7.3±8.0, p<0.001). On PSIR, ≥1 IC lesion was seen in 60/60 MS patients and 1/30 controls, and ≥1 LC lesion in 60/60 patients and 6/30 controls. On DIR, ≥1 IC lesion was seen in 50/60 patients and 0/30 controls, and ≥1 LC lesion(s) in 60/60 patients and 5/30 controls.
CONCLUSIONS: Compared with DIR, using PSIR the authors are able to detect a significantly greater number of cortical grey matter lesions. The presence of at least one IC lesion in every MS patient, but very few healthy controls, suggests that it may be a useful adjunct to conventional MRI when a diagnosis of MS is suspected but not confirmed.

Entities:  

Mesh:

Year:  2012        PMID: 22807559     DOI: 10.1136/jnnp-2012-303023

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  61 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

Authors:  Mike P Wattjes; Àlex Rovira; David Miller; Tarek A Yousry; Maria P Sormani; Maria P de Stefano; Mar Tintoré; Cristina Auger; Carmen Tur; Massimo Filippi; Maria A Rocca; Franz Fazekas; Ludwig Kappos; Chris Polman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

Review 2.  Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.

Authors:  C McNamara; G Sugrue; B Murray; P J MacMahon
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

3.  Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis.

Authors:  M Castellaro; R Magliozzi; A Palombit; M Pitteri; E Silvestri; V Camera; S Montemezzi; F B Pizzini; A Bertoldo; R Reynolds; S Monaco; M Calabrese
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

4.  Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI.

Authors:  J Maranzano; M Dadar; D A Rudko; D De Nigris; C Elliott; J S Gati; S A Morrow; R S Menon; D L Collins; D L Arnold; S Narayanan
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-20       Impact factor: 3.825

Review 5.  Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.

Authors:  Hugh Kearney; David H Miller; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2015-05-26       Impact factor: 42.937

Review 6.  Grey matter damage in multiple sclerosis: a pathology perspective.

Authors:  Roel Klaver; Helga E De Vries; Geert J Schenk; Jeroen J G Geurts
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 7.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

8.  In vivo detection of connectivity between cortical and white matter lesions in early MS.

Authors:  Jan-Mendelt Tillema; Stephen D Weigand; Jay Mandrekar; Yunhong Shu; Claudia F Lucchinetti; Istvan Pirko; John D Port
Journal:  Mult Scler       Date:  2016-10-03       Impact factor: 6.312

9.  2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times.

Authors:  Nico Papinutto; Regina Schlaeger; Valentina Panara; Eduardo Caverzasi; Sinyeob Ahn; Kevin J Johnson; Alyssa H Zhu; William A Stern; Gerhard Laub; Stephen L Hauser; Roland G Henry
Journal:  J Magn Reson Imaging       Date:  2014-12-08       Impact factor: 4.813

10.  Automated patient-specific optimization of three-dimensional double-inversion recovery magnetic resonance imaging.

Authors:  Refaat E Gabr; Xiaojun Sun; Amol S Pednekar; Ponnada A Narayana
Journal:  Magn Reson Med       Date:  2015-03-11       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.